Navigation Links
New text focuses on formidable opportunistic fungus
Date:12/12/2008

Modern medical technologies are repairing the human body in ways never imagined only a few years ago, but they are leaving an increasing population of patients who are newly susceptible to opportunistic pathogens. Invasive and chronic fungal infections have become a formidable clinical opponent, and foremost among them is Aspergillus fumigatus, the focus of a new text from ASM Press.

"This volume has been carefully engineered to offer the latest insights into the fundamental biology and pathogenesis of this organism and how it establishes disease, as well as the newest strategies for characterizing, diagnosing, and treating its spectrum of clinical infection. Other great textbooks have been published which address general fungal physiology, overall medical mycology, the biology of the aspergilli specifically, or antifungal therapy, yet this is the first volume which specifically merges the newest scientific knowledge with the latest clinical experience and data to yield a combined synopsis of the organism and its diseases," says Jean-Paul Latg of the Institut Pasteur who co-edited the text with William J. Steinbach of Duke University.

Aspergillus fumigatus and Aspergillosis assembles chapters from a large and international contingent of experts in the field to explore every major aspect of A. fumigatus and how it kills so many patients. This volume offers the latest insights into the fundamental biology and pathogenesis of A. fumigatus and how it establishes disease, as well as the newest strategies for characterizing, diagnosing, and treating its spectrum of clinical infection.

This valuable book is an instrumental resource for both scientists and clinicians tackling the current problems with Aspergillosis. It presents chapters on the species itself, including morphology and unique and specific genes, the importance of polarized growth, as well as the organism's response to environmental stress by moving from a saprophyte to a pathogen. The interface with the host immune systemparamount to disease phenotypeis detailed, as are the many faces of disease created by A. fumigatus. Newer diagnostic and treatment strategies are covered, including the optimal timing of antifungal therapy and the strategic choice of which agent to use.

"It is our intent that Aspergillus fumigatus and Aspergillosis will encompass the current state of knowledge to serve as a resource guide for the next decade of study on this organism and the many diseases it causes. We hope that this volume will also serve as a catalyst for future young investigators to begin their own explorations in this field, to challenge the unproven dogmas and define the mechanisms of disease," says Latg.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Related biology news :

1. Project focuses on production of hydrogen from bacteria and sunlight
2. New lab manual focuses on essential methods for purifying and characterizing proteins
3. Text focuses on diagnosing infections in immunocompromised patients
4. Fungus genome yielding answers to protect grains, people and animals
5. Scientists complete genome sequence of fungus responsible for dandruff, skin disorders
6. Scientists find missing evolutionary link using tiny fungus crystal
7. Evolution of the sexes: What a fungus can tell us
8. Killer fungus spells disaster for wheat
9. Smithsonians National Museum of Natural History reveals ants as fungus farmers
10. Lean and mean biomass-degrading fungus reveals capabilities for improved biofuel production
11. Turning fungus into fuel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
(Date:2/7/2017)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the latest release of ... and award winning eClinical solution, is now available for ... a proven Software-as-a-Service (SaaS) clinical research technology platform that ... delivers an entire suite of eClinical tools to support ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... by its Chairman and CEO, Jim Joyce . ... Security Conference last Saturday, Bill Gates warned ... more people than nuclear weapons. Mr. Gates expressed his ... intelligence agencies, that scientific terrorists have access to the ...
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
(Date:2/23/2017)... and NEW YORK ... HIMSS, Lumeon , a leading digital health ... Telehealth), a provider of telemedicine and remote patient ... pathways for telemedicine reimbursements.  DN ... their patients, in real-time, extending consultations beyond a ...
(Date:2/23/2017)... JOSE, Calif. , Feb. 23, 2017 /PRNewswire/ ... exclusive license for two key immunotherapy technologies from ... first technology provides a method to monitor a ... such as PD-L1 and CTLA-4.  The second license ... if a patient is likely to have an ...
Breaking Biology Technology: